Jump to ContentJump to Main Navigation

Open Medicine

formerly Central European Journal of Medicine

1 Issue per year


IMPACT FACTOR 2014: 0.153
5-year IMPACT FACTOR: 0.183

SCImago Journal Rank (SJR) 2014: 0.135
Source Normalized Impact per Paper (SNIP) 2014: 0.124
Impact per Publication (IPP) 2014: 0.193

Open Access
VolumeIssuePage

Issues

Coffee consumption and type 2 diabetes — An extensive review

1Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute, Helsinki, Finland

2Department of Public Health, University of Helsinki, Helsinki, Finland

3South Ostrobothnia Central Hospital, Seinäjoki, Finland

© 2008 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. (CC BY-NC-ND 3.0)

Citation Information: Open Medicine. Volume 3, Issue 1, Pages 9–19, ISSN (Online) 2391-5463, DOI: 10.2478/s11536-007-0059-6, March 2008

Publication History

Published Online:
2008-03-01

Abstract

Coffee is a complex mixture of potentially active chemicals. It contains significant amounts of phenolic polymers, chlorogenic acid and also caffeine. Agricultural factors, roasting, blending, and brewing determine coffee’s chemical composition. Recent epidemiological studies suggest that habitual coffee consumption may help to prevent some chronic diseases including type 2 diabetes. Despite reports from the clinical trials of the effect of caffeine on decreasing insulin sensitivity, long-term prospective studies revealed that coffee may improve fasting glucose, glucose tolerance and insulin sensitivity as well. In the most recent publication habitual coffee drinkers have a lower total and cardiovascular mortality rate among diabetic subjects.

Keywords: Coffee; Type 2 diabetes; Glucose tolerance

  • [1] Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 2004, 27, 1047–1053 http://dx.doi.org/10.2337/diacare.27.5.1047 [CrossRef]

  • [2] Amos A.F., McCarty D.J. and Zimmet P., The rising global burden of diabetes and its complications: Estimates and projections to the year 2010, Diabet. Med., 1997, 14, S7–S85 http://dx.doi.org/10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-I [CrossRef]

  • [3] Bennett P.H., Type 2 diabetes among the Pima Indians of Arizona: an epidemic attributable to environmental change, Nutrition Reviews, 1999, 57, S51–54 http://dx.doi.org/10.1111/j.1753-4887.1999.tb01788.x [CrossRef]

  • [4] Lako J.V., Nguyen V.C., Dietary patterns and risk factors of diabetes mellitus among urban indigenous women in Fiji, Asia Pacific J. of Clin. Nutr., 2001, 10, 188–193 http://dx.doi.org/10.1046/j.1440-6047.2001.00255.x [CrossRef]

  • [5] Hetzel B., Michael T., The lifestyle factor: Lifestyle and health, Melbourne Pinguin, 1987.

  • [6] Tuomilehto J., Tuomilehto-Wolf E., Zimmet P., Alberti K.G.M.M., Knowler W.C., Primary prevention of diabetes mellitus, In: Alberti K.G.M.M., Zimmet P., DeFronzo R.A., Keen H. (Eds.) International Textbook of Diabetes Mellitus, 2nd ed., Wiley, Chichester New York Brisban Toronto, 1997

  • [7] Clifford M.N., Chlorogenic acid and other cinnamates-nature, occurrence and dietary burden, J. Sci. Food Agric., 1999, 79, 362–372 http://dx.doi.org/10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D [CrossRef]

  • [8] Clifford M.N., Chlorogenic acid and other cinnamates-nature, occurrence, dietary burden, absorption and metabolism, J. Sci. Food Agric., 2000, 80, 1033–1043 http://dx.doi.org/10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T [CrossRef]

  • [9] Nauck M.A., Heimesaat M.M., Orskov C., Holst J.J., Ebert R., Creutzfeldt W., Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus, J. Clin. Invest., 1993 91, 301–307

  • [10] Meier J.J., Hucking K., Holst J.J., Deacon C.F., Schmiegel W.H., Nauck M.A., Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes”, Diabetes, 2001, 50, 2497–2504 http://dx.doi.org/10.2337/diabetes.50.11.2497 [CrossRef]

  • [11] Tuomilehto J., Tuomilehto-Wolf E., Virtala E., LaPorte R., Coffee consumption as trigger for insulin dependent diabetes mellitus in childhood, B.M.J., 1990, 300, 642–643

  • [12] Barbagallo M., Dominguez L.J., Galioto A., Ferlisi A., Cani C., Malfa L., et al., Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X, Mol. Aspects Med., 2003, 24, 39–52 http://dx.doi.org/10.1016/S0098-2997(02)00090-0 [CrossRef]

  • [13] Paolisso G., Scheen A., D’Onofrio F., Lefebvre P., Magnesium and glucose homeostasis, Diabetologia, 1990, 33, 511–514 http://dx.doi.org/10.1007/BF00404136 [CrossRef]

  • [14] Paolisso G., Ravussin E., Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians, J. Clin. Endocrinol. Metab., 1995, 80, 1382–1385 http://dx.doi.org/10.1210/jc.80.4.1382 [CrossRef]

  • [15] Paolisso G., Barbagallo M., Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium, Am. J. Hypertens., 1997, 10, 346–355 http://dx.doi.org/10.1016/S0895-7061(96)00342-1 [CrossRef]

  • [16] Matsui T., Ueda T., Oki T., Sugita K., Terahara N., Matsumoto K., alpha-Glucosidase inhibitory action of natural acylated anthocyanins. 2. Alpha-Glucosidase inhibition by isolated acylated anthocyanins, J. Agric. Food. Chem., 2001, 49, 1952–1956 http://dx.doi.org/10.1021/jf0012502 [CrossRef]

  • [17] Kobayashi Y., Suzuki M., Satsu H., Arai S., Hara Y., Suzuki K., et al., Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism, J. Agric. Food. Chem., 2000, 48, 5618–5623 http://dx.doi.org/10.1021/jf0006832 [CrossRef]

  • [18] Nauck M.A., Heimesaat M.M., Orskov C., Holst J.J., Ebert R., Creutzfeldt W., Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus, J. Clin. Invest., 1993, 91, 301–307 [CrossRef]

  • [19] Meier J.J., Hucking K., Holst J.J., Deacon C.F., Schmiegel W.H., Nauck M.A., Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes, Diabetes, 2001, 50, 2497–2504 http://dx.doi.org/10.2337/diabetes.50.11.2497 [CrossRef]

  • [20] Newgard C.B., Foster D.W., McGarry J.D., Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding, Diabetes, 1984, 33, 192–195 http://dx.doi.org/10.2337/diabetes.33.2.192 [CrossRef]

  • [21] Youn J.H., Youn M.S., Bergman R.N., Synergism of glucose and fructose in net glycogen synthesis in perfused rat livers, J. Biol. Chem., 1986, 261, 15960–15969

  • [22] Arion W.J., Canfield W.K., Ramos F.C., Schindler P.W., Burger H.J., Hemmerle H., et al., Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase, Arch. Biochem. Biophys., 1997, 339, 315–322 http://dx.doi.org/10.1006/abbi.1996.9874 [CrossRef]

  • [23] Andrade-Cetto A., Wiedenfeld H., Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats, J. Ethnopharmacol., 2001, 78, 145–149 http://dx.doi.org/10.1016/S0378-8741(01)00335-X [CrossRef]

  • [24] Keijzers G.B., De Galan B.E., Tack C.J., Smits P., Caffeine can decrease insulin sensitivity in humans, Diabetes Care, 2002, 25, 364–369 http://dx.doi.org/10.2337/diacare.25.2.364 [CrossRef]

  • [25] Denaro C.P., Brown C.R., Jacob P., Benowitz N.L., Effects of caffeine with repeated dosing, Eur. J. Clin. Pharmacol., 1991, 40, 273–278 http://dx.doi.org/10.1007/BF00315208 [CrossRef]

  • [26] Arnlov J., Vessby B., Riserus U., Coffee consumption and insulin sensitivity, JAMA, 2004, 291, 1199–1201. http://dx.doi.org/10.1001/jama.291.10.1199-b [CrossRef]

  • [27] Yeni-Komshian H., Carantoni M., Abbasi F., Reaven G.M., Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers, Diabetes Care, 2002, 23, 171–175 http://dx.doi.org/10.2337/diacare.23.2.171 [CrossRef]

  • [28] Laakso M., How good is insulin level for insulin resistance?, Am. J. Epidemiol., 1992, 137, 959–965

  • [29] Ferrannini E. Mari A., How to measure insulin sensitivity, J. Hypertens., 1998, 16, 895–906 http://dx.doi.org/10.1097/00004872-199816070-00001 [CrossRef]

  • [30] Haffner S.M., Valdez R.A., Hazuda H.P., Mitchell B.D., Moralles P.A. Stern M.P., Prospective analaysis of the insulin-resistance syndrome (syndrome X), Diabetes, 1992, 41, 715–722 http://dx.doi.org/10.2337/diabetes.41.6.715 [CrossRef]

  • [31] Zavaroni I., Bonora E., Pagliara M., Dall’Aglio E., Luchetti L., Buonanno G., et al., Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance, N. Eng. J. Med., 1989, 320, 702–706 http://dx.doi.org/10.1056/NEJM198903163201105 [CrossRef]

  • [32] Despres J.P., Lamarch B., Maurige P., Cantin B., Dagenais G.R., Moorjani S., et al., Hyperinsulinemia as an independent risk factor for ischemic heart disease, N. Eng. J. Med., 1996, 334, 952–957 http://dx.doi.org/10.1056/NEJM199604113341504 [CrossRef]

  • [33] Fontbonne A., Charles M.A., Thibult N., Richard J.L., Claude J.R., Warnet J.M., et al., Hyperinsulinemia as a predictor of coronary heart disease mortality in healthy population: the Paris Prospective Study, 15-year follow-up, Diabetologia, 1991, 34, 356–361 http://dx.doi.org/10.1007/BF00405009 [CrossRef]

  • [34] Panagiotakos D.B., Pitsavos C., Zampelas A., Zeimbekis A., Chrysohoou C., Papademetriou L., et al., The association between coffee consumption and plasma total homocysteine levels: the “ATTICA” study, Heart. Vessels., 2004, 19, 280–286 http://dx.doi.org/10.1007/s00380-004-0779-3 [CrossRef]

  • [35] Panagiotakos D.B., Pitsavos C,. Zeimbekis A., Chrysohoou C., Stefanadis C., The association between lifestyle-related factors and plasma homocysteine levels in healthy individuals from the “ATTICA” Study, Int. J. Cardiol., 2005, 98, 471–477 http://dx.doi.org/10.1016/j.ijcard.2003.12.036 [CrossRef]

  • [36] Jacques P.F., Bostom A.G., Wilson P.W., Rich S., Rosenberg I.H., Selhub J., Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort, Am. J. Clin. Nutr., 2001, 73, 613–621

  • [37] Martos R., Valle M., Morales R., Canete R., Gavilan M.I., Sanchez-Margalet V., Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic inflammation in obese prepubertal children, Metabolism., 2006, 55, 72–77 http://dx.doi.org/10.1016/j.metabol.2005.07.008 [CrossRef]

  • [38] Cho N.H., Lim S., Jang H.C., Park H.K., Metzger B.E., Elevated homocysteine as a risk factor for the development of diabetes in women with a previous history of gestational diabetes mellitus: a 4-year prospective study, Diabetes Care., 2005, 28, 2750–2755 http://dx.doi.org/10.2337/diacare.28.11.2750 [CrossRef]

  • [39] Peyrin-Biroulet L., Gueant J.L., Roblin X., Coffee and diabetes: is homocysteine the missing link?, Arch. Intern. Med., 2007, 167, 204 http://dx.doi.org/10.1001/archinte.167.2.204-a [CrossRef]

  • [40] Mascitelli L., Pezzetta F., Sullivan J.L., Inhibition of iron absorption by coffee and the reduced risk of type 2 diabetes mellitus, Arch. Intern. Med., 2007, 167, 204–205 http://dx.doi.org/10.1001/archinte.167.2.204-b [CrossRef]

  • [41] Jiang R., Manson J.E., Meigs J.B., Ma J., Rifai N., Hu F.B., Body iron stores in relation to risk of type 2 diabetes in apparently healthy women, JAMA., 2004, 291, 711–717 http://dx.doi.org/10.1001/jama.291.6.711 [CrossRef]

  • [42] Facchini F.S., Saylor K.L., Effect of iron depletion on cardiovascular risk factors: studies in carbohydrate intolerant patients, Ann. N. Y. Acad. Sci. 2002, 967, 342–351 http://dx.doi.org/10.1111/j.1749-6632.2002.tb04290.x [CrossRef]

  • [43] Petrie H.J., Chown S.E., Belfie L.M., Duncan A.M., McLaren D.H., Conquer J.A., et al., Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss, Am. J. Clin. Nutr., 2004, 80, 22–28

  • [44] Graham T.E., Sathasivam P., Rowland M., Marko N., Greer F., Battram D., Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test, Can. J. Physiol. Pharmacol., 2001, 79, 559–565 http://dx.doi.org/10.1139/cjpp-79-7-559 [CrossRef]

  • [45] Greer F., Hudson R., Ross R., Graham T., Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans, Diabetes, 2001, 50, 2349–2354 http://dx.doi.org/10.2337/diabetes.50.10.2349 [CrossRef]

  • [46] Naismith, D.J., Akinyanju, P.A., Szanto, S., Yudkin J., The effect in volunteers of coffee and decaffeinated coffee on blood glucose, insulin, plasma lipids and some factors involved in blood clotting, Nutr. Metab., 1970, 12, 144–151 http://dx.doi.org/10.1159/000175287 [CrossRef]

  • [47] Van Dam R.M., Pasman W.J., Verhoef P., Effects of coffee consumption on fasting blood glucose and insulin concentrations: randomized controlled trials in healthy volunteers, Diabetes Care, 2004, 27, 2990–2992 http://dx.doi.org/10.2337/diacare.27.12.2990 [CrossRef]

  • [48] Battram D.S., Arthur R., Weekes A., Graham T.E., The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men, J. Nutr., 2006, 136, 1276–1280

  • [49] Yamaji T., Mizoue T., Tabata S., Ogawa S., Yamaguchi K., Shimizu E., et al., Coffee consumption and glucose tolerance status in middle-aged Japanese men, Diabetologia, 2004, 47, 2145–2151 http://dx.doi.org/10.1007/s00125-004-1590-5 [CrossRef]

  • [50] Soriguer F., Rojo-Martinez G., de Antonio I.E., Coffee consumption and type 2 diabetes mellitus, Ann. Intern. Med. 2004, 141, 321–323

  • [51] Agardh E.E., Carlsson S., Ahlbom A., Efendic S., Grill V., Hammar N., et al., Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women, J. Intern. Med., 2004, 255, 645–652 http://dx.doi.org/10.1111/j.1365-2796.2004.01331.x [CrossRef]

  • [52] Van Dam R.M., Dekker J.M., Nijpels G., Stehouwer C.D., Bouter L.M., Heine R.J., Hoorn study: “Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study, Diabetologia, 2004, 47, 2152–2159 http://dx.doi.org/10.1007/s00125-004-1573-6 [CrossRef]

  • [53] Bidel S., Hu G., Sundvall J., Kaprio J., Tuomilehto J., Effects of coffee consumption on glucose tolerance and serum glucose and insulin levels-A cross sectional analysis, Horm. Metab. Res., 2006, 38, 38–43 http://dx.doi.org/10.1055/s-2006-924982 [CrossRef]

  • [54] Van Dam R.M., Feskens E.J., Coffee consumption and risk of type 2 diabetes mellitus, Lancet, 2002, 360, 1477–1478 http://dx.doi.org/10.1016/S0140-6736(02)11436-X [CrossRef]

  • [55] Salazar-Martinez E., Willett W.C., Ascherio A., Manson J.E., Leitzmann M.F., Stampfer M.J., et al., Coffee consumption and risk for type 2 diabetes mellitus, Ann. Intern. Med., 2004, 140, 1–8

  • [56] Carlsson S., Hammar N., Grill V., Kaprio J., Coffee consumption and risk of type 2 diabetes in Finnish twins, Int. J. Epidemiol., 2004, 3, 616–617 http://dx.doi.org/10.1093/ije/dyh185 [CrossRef]

  • [57] Rosengren A., Dotevall A., Wilhelmsen L., Thelle D., Johansson S., Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow up study, J. Intern. Med., 2004, 255, 89–95 http://dx.doi.org/10.1046/j.1365-2796.2003.01260.x [CrossRef]

  • [58] Paynter N.P., Yeh H.C., Voutilainen S., Schmidt M.I., Heiss G., Folsom A.R., et al., Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study, Am. J. Epidemiol., 2006, 164, 1075–1084 http://dx.doi.org/10.1093/aje/kwj323 [CrossRef]

  • [59] Pereira M.A., Parker E.D., Folsom A.R., Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women, Arch. Intern. Med., 2006, 166, 1311–1316 http://dx.doi.org/10.1001/archinte.166.12.1311 [CrossRef]

  • [60] Van Dam R.M., Willett W.C., Manson J.E., Hu F.B., Coffee, Caffeine, and Risk of Type 2 Diabetes: A prospective cohort study in younger and middle-aged U.S. women, Diabetes Care, 2006, 29, 398–403 http://dx.doi.org/10.2337/diacare.29.02.06.dc05-1512 [CrossRef]

  • [61] Iso H., Date C., Wakai K., Fukui M., Tamakoshi A., The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults, Ann. Intern. Med., 2006, 144, 554–562

  • [62] Reunanen A., Heliovaara M., Aho K., Coffee consumption and risk of type 2 diabetes mellitus, Lancet, 2003, 361, 702–703 http://dx.doi.org/10.1016/S0140-6736(03)12583-4 [CrossRef]

  • [63] Tuomilehto J., Hu G., Bidel S., Lindstrom J., Jousilahti P., Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women, JAMA, 2004, 291, 1213–1219 http://dx.doi.org/10.1001/jama.291.10.1213 [CrossRef]

  • [64] Saremi A., Tulloch-Reid M., Knowler W.C., Coffee consumption and the incidence of type 2 diabetes”, Diabetes Care, 2003, 7, 2211–2212 http://dx.doi.org/10.2337/diacare.26.7.2211 [CrossRef]

  • [65] Van Dam R.M., Hu F.B., Coffee consumption and risk of type 2 diabetes: a systematic review, JAMA, 2005, 294, 97–104 http://dx.doi.org/10.1001/jama.294.1.97 [CrossRef]

  • [66] Hu G., Jousilahti P., Peltonen M., Bidel S., Tuomilehto J., Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland, Int. J. Obes., 2006, 30, 1742–1749 http://dx.doi.org/10.1038/sj.ijo.0803341 [CrossRef]

  • [67] Perry I.J., Wannamethee S.G., Sharper A.G., Prospective study of serum g-glutamyltransferase and risk of NIDDM, Diabetes Care, 1998, 21,732–737 http://dx.doi.org/10.2337/diacare.21.5.732 [CrossRef]

  • [68] Nakanishi N., Suzuki K., Tatar K., Serum g-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men, Diabetes Care, 2004, 27, 1427–1432 http://dx.doi.org/10.2337/diacare.27.6.1427 [CrossRef]

  • [69] Bidel S., Silventoinen K., Hu G., Lee D.H., Kaprio J., Tuomilehto J., Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes, Eur. J. Clin. Nutr., 2007, doi:10.1038/sj.ejcn.1602712, 1–8 [CrossRef]

  • [70] Lee D.H., Jacobs D.R. Jr., Gross M., Kiefe C.I., Roseman J., Lewis C.E., et al., Gammaglutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study, Clin. Chem., 2003, 49, 1358–1366 http://dx.doi.org/10.1373/49.8.1358 [CrossRef]

  • [71] Bidel S., Hu G., Qiao Q., Jousilahti P., Antikainen R., Tuomilehto J., Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes, Diabetologia, 2006, 49, 2618–2626 http://dx.doi.org/10.1007/s00125-006-0435-9 [CrossRef]

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Maria Ceymann, Eva Arrigoni, Hans Schärer, Anna Bozzi Nising, and Richard F. Hurrell
Journal of Food Composition and Analysis, 2012, Volume 26, Number 1-2, Page 128
[2]
Rakesh Jaiswal, Marius Febi Matei, Frank Ullrich, and Nikolai Kuhnert
Journal of Mass Spectrometry, 2011, Volume 46, Number 9, Page 933
[3]
Aneta Berner-Strzelczyk, Justyna Kołodziejska, Magdalena Piechota-Urbañska, Mariusz Piechota, and Marian Zgoda
Open Medicine, 2009, Volume 4, Number 1

Comments (0)

Please log in or register to comment.